An update from QHSLab ( ($USAQ) ) is now available. On December 31, 2025, QHSLab, Inc. entered into a Promissory Note Modification and Partial ...

Investing.com - Jefferies maintained its Buy rating and $79.00 price target on Structure Therapeutics (NASDAQ:GPCR) following the company’s Phase 2b data for its small molecule GLP1 receptor agonist, ...

Investing.com -- iPower Inc. (NASDAQ:IPW) stock tumbled 7% on Tuesday after the e-commerce company announced a $30 million convertible note financing facility to launch a Digital Asset Treasury ...

London Stock Exchange ( (GB:LSEG)) has shared an announcement. London Stock Exchange Group PLC has executed a share buyback program, purchasing 318,000 of its ordinary shares from Citigroup Global ...

Warren Buffett has spent a lifetime proving that simple investing beats complicated schemes, and his so‑called 90/10 rule is ...

Explore the concept of bullet loans and bonds, their differences from amortizing loans, and their impact on borrowers and issuers. Understand how these financial tools work.

Shareholders were extremely pleased by the biotech's latest news from the lab. This concerned its pipeline weight-loss drug aleniglipron. Structure, which concentrates on metabolic diseases with a ...

Investing.com -- Structure Therapeutics Inc. (NASDAQ:GPCR) stock fell 4.1% in after-hours trading Monday following the announcement of a proposed $500 million public offering, giving back some of its ...

Seeking Alpha is proud to welcome Vega North as a new contributing analyst. You can become one too! Share your best ...

Learn about capitalization structure and how the combination of debt and equity a company uses to fund operations can affect its profitability.